February 2017 | Volume 2




"This year, and over the next five years, we will continue to see the creation of new tools, implants and techniques derived from advances in additive manufacturing, or 3D printing, as well as the ongoing integration of computers and robotic systems into surgical practice."
 




Orthopaedic device companies seeking to capitalize on the trends of outsourcing and alternative payments would be best suited to target progressive hospitals.  
AAOS continues to attract supplier and service providers. So, not only will your surgeon customers be attending, but so will many of your current and potential partners.

In addition to the financial review, portfolio fit and savings potential of post-close synergies, identify supply chain risks and opportunities, explains David Finch in these 3 articles: 


Zimmer Biomet is recalling 3,662 units of the Comprehensive Reverse Shoulder due to a higher rate of fracture occurrence than was stated in the labeling.

The acquired platforms represent a polyaxial interspinous process device and percutaneous facet screw system designed for MIS applications in the lumbar spine, and provide supplemental fixation when used with Wenzel Spine's standalone, expandable VariLift-LX interbody fusion device.
The 12-site prospective, randomized study is underway in France, Germany, Italy, Spain and Switzerland to support a planned FDA 510(k) submission by the end of 2017.